deucravacitinib
bms
[]
deuc showed statistically significant and sustained clinical efficacy in sri(4) responses versus pbo and was well tolerated in sle. plenary abs 1117 #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.